Literature DB >> 31015110

Comparison of electromagnetic transmitter and ultrasound imaging for intrafraction monitoring of prostate radiotherapy.

Marie-Claude Biston1, Timothée Zaragori2, Laurent Delcoudert2, Marie Fargier-Voiron2, Alexandre Munoz2, Coralie Gorsse2, David Sarrut3, Pascal Pommier2.   

Abstract

BACKGROUND AND
PURPOSE: To compare two in-beam monitoring devices for prostate radiotherapy: intra-prostatic electromagnetic transmitters (EM-T) (RayPilot®, Micropos Medical) and ultrasound imaging using transperineal probe (TP-US) (Clarity®, Elekta) used concomitantly on phantom and on patients.
MATERIALS AND METHODS: The phantom study evaluated accuracy in presence of known translations and rotations. Then intra-fraction motions were analyzed for 10 prostate cancer patients implanted with the EM-T 8 days before the simulation CT (171 sessions). The percent time in which the differences between the systems were 1-5 mm were scored for each direction.
RESULTS: Experiments on phantom confirmed no interference between the systems and showed deviations of less than 0.5 mm when translations were applied progressively. In presence of rotations (5-15°), both systems displayed systematic shifts up to 6.9 and 3.8 mm for the TP-US and the EM-T, respectively. Absolute mean differences between displacements observed on patients with EM-T and TP-US were ≤0.55 mm in all directions except for one patient (≤1.77 mm). With an exception for this patient, a strong correlation was found in left-right direction: differences >2 mm were monitored less than 0.22% of the time (mean acquisition time:164 minutes) and never exceeded 5 s. Maximum differences were observed in supero-inferior direction with differences >2 mm monitored more than 6.5% of the time for 3 patients. Large prostate rotations, the presence of gas and EM-T location in the prostate may explain important differences.
CONCLUSION: Apart from the systematic shifts induced by the rotations, the two systems were correlated and represent feasible solutions for monitoring prostate cancer treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electromagnetic transmitters; Image-guided radiotherapy; Monitoring; Prostate cancer; Ultrasounds

Mesh:

Year:  2019        PMID: 31015110     DOI: 10.1016/j.radonc.2019.03.020

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching.

Authors:  Alexander Grimwood; Hassan Rivaz; Hang Zhou; Helen A McNair; Klaudiusz Jakubowski; Jeffrey C Bamber; Alison C Tree; Emma J Harris
Journal:  Radiother Oncol       Date:  2020-05-06       Impact factor: 6.280

2.  Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.

Authors:  Subaru Sawayanagi; Hideomi Yamashita; Mami Ogita; Ryosuke Takenaka; Yuki Nozawa; Yuichi Watanabe; Toshikazu Imae; Osamu Abe
Journal:  Radiat Oncol       Date:  2022-02-23       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.